Please provide your email address to receive an email when new articles are posted on . Adults with obesity saw improvements in glycemic response and endothelial function after a 14-day intervention ...
Cyclingnews on MSN
UCI recommends against use of legal ketone supplements among professional cyclists due to lack of evidence of performance benefits
"As there is no compelling evidence that ketone supplements enhance performance or recovery, the UCI sees no reason for them ...
Abbott is designing a first-of-its-kind biowearable that will enable people with diabetes to continuously monitor glucose and ketones in one sensor Device promises to redefine care for people with ...
Ketones are a type of acid your body produces when it needs to break down body fat for energy. Trace amounts of ketones in your urine aren’t usually a cause for concern, but high levels can indicate a ...
Cycling Weekly on MSN
UCI 'does not recommend' use of ketones in cycling, but does not restrict their use
The UCI has announced that it "does not recommend" the use of ketones in cycling, but will not restrict their use, it was ...
Gluconeogenesis and ketogenesis are regarded as important for preserving blood glucose homeostasis in human newborns. We have studied simultaneously ketone body (KB) and glucose turnover rates in six ...
People with obesity may have a higher risk of cognitive impairment, such as difficulty making decisions or remembering. A small study involving oral ketone supplementation for 14 days suggests an ...
Beta Bionics plans to integrate its iLet Bionic Pancreas with Abbott's upcoming dual glucose-ketone sensor for enhanced diabetes management. Beta Bionics, Inc. has announced plans to integrate its ...
News Medical on MSN
New Study in Mice Reveals Long-Term Metabolic Risks of Ketogenic Diet
The new study, performed with mice, demonstrates that the diet can have potentially dangerous impacts on metabolic health, ...
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced an agreement to develop and commercialize integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results